could semaglutide become a future treatment for alcohol use disorder?, A new randomized, double-blind, placebo-controlled trial published in The Lancet examined semaglutide 2.4 mg in treatment-seeking Some people are overdosing on

This forces a large number of growing hair follicles to enter the resting (Telogen) phase prematurely

The medications, originally developed for diabetes, are becoming increasingly popular for weight loss, but until now, it seemed as if once a person started taking them, they had to take them forever to keep weight off

Zepbound is currently FDA-approved for the treatment of moderate to severe OSA in adults who: Its not intended for people with mild OSA or those who already manage their sleep apnea successfully through CPAP or other devices

This partial reversal may be driven by factors such as compliance challenges, waning drug efficacy, or measurement limitations